Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers (1999)

Peer-Reviewed Study · Simonsen AC; Sørensen H · 1999

Simonsen AC et al., 1999: Randomised crossover trial in 12 healthy volunteers receiving autologous methylene blue-treated versus untreated fresh frozen plasma: no clinical or biochemical difference and no effect on coagulation proteins.

No clinical or statistically significant difference was detected for any of the parameters.

Abstract

Simonsen AC et al., 1999: Randomised crossover trial in 12 healthy volunteers receiving autologous methylene blue-treated versus untreated fresh frozen plasma: no clinical or biochemical difference and no effect on coagulation proteins. Study type: randomised crossover clinical trial in healthy volunteers. N=12, Denmark. Product: Baxter's methylene blue photoinactivation with a filtration step. Comparator: untreated autologous FFP. Outcomes: coagulation, clinical and biochemical parameters. Funding/COI not stated in retrieved abstract record. Small N and healthy volunteers , tolerance data only, not efficacy. Study type: randomized trial.